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Risk assessments for nongenotaic chemicals assume a thrshold bdow which no adverse out-
comes areseen. However, when anendogenous ecal, such as 17f-estradiol (E2), occurs ata
concenttion suffcient to cause an effct, the reshold is arady xceded. Under these cir-
cumstances, exogenous estradiol is not expected to provide a threshold dose. This principle is
demontrated for E2 in the red-eared dider, aturdlewith meatueddent sex determina-
tion. In this species, gonadal se is determined byegg incubation ure; male develop-
mentrequires endeous estrogen produced byelevated temperature. Whilenormalproduction
offemales byendogenous esrgns is not an adverseeffc, exogenous esgens can sex reverse
presumptive males, which can be an adverse effect. A lar dos-response studywas conducted
using seven doses and avehide control (starng n m 300/group); a single E2 dosew applied to
theegghellofrecentlylaid egg. Animal were sexedafter ing. Theincubtiontemperature
chosen, 28.6°C, generaes a minority of females. Thus, the criteria for testing the threshold
hypothesis were met, i.e., there is evidence that there is endous estrogen and that it gener-
ates an irreversible response. The lowest E2dose tested, 400 pgegg (40 ng/kg), se reversed
14.4% ofthe animals, demonstrtingvery low dose itvity The datawere fit with a modi-
fied Michaelis-Menten equation, which provided an estimate of 1.7 ng/egg for endogenous
estradiol. The median effeciv dose (ED,d was 5.0 * 2.0 angegg (95% confidence limits), of
which 1.7 ag/egg was endogenous estradiol and 3.3 ng/egg came from the applied estradioL
There wa no apparent threshold dose for E2. A smaller replication confirmed these results.
These results provide a simple biologiclly based dose-response modd and sust that chemi-
cal which act mechanistically likeE2may alo show no threshold dose. Ifso, even low environ-
mental concentrations ofsuch. ms may carry risk for sex reveral. Key wordk: biologically
baseddose-rsponse model, development, edorieiisrptrspetroen,,is assessment, saf-
ty testing, sex determination, sex reversal, threshold, turtle. Environ Health Perspect
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Endogenous estrogens are required for prop-
er growth and development ofseveral mam-
malian tissues, including the male and
female reproductive tracts. This organiza-
tional effect ofestrogens programs not only
certain features of normal adult structures
but also responsiveness to estrogens in adult-
hood, the latter termed the activational
effect. Additionally, the organizational effect
ofestrogens appears to act through the same
mechanisms that activate genes in adults.
Some estrogen responses are activated by
endogenous estrogens during development
(1,2). These features are important in
understanding why exposure during critical
periods ofdevelopment to very low doses of
a variety ofchemicals with estrogenic activi-
ty can irreversibly alter reproductive tract
development, leading to adverse effects.
Estrogens are involved in normal female
development of many organisms with tem-
perature-dependent sexdetermination (TSD),
induding turtles. In the red-eared slider turtle
(Trachemys scrzpta elegans), sex is determined
by the incubation temperature of the egg
(rather than by sex chromosomes) during the
middle third of incubation, a window of
time called the temperature-sensitive period
(TSP). An egg incubation temperature of
26.60C produces all males, and a tempera-
tures of 31°C produces all females (3). A
male:female ratio of about 1:1 is found at
29.20C (4). As temperature increases from
28.8 to 29.6'C, the sex ratio changes from
9:1 male:female to 9:1 female:male (4).
Administration ofexogenous estradiol (E2)
or hydroxylated polychlorinated biphenyls
(PCBs) to eggs incubated at all-male or
male-biased temperatures results in females,
overriding the temperature effect (5,6).
Additionally, when eggs are incubated at
increasing temperatures that progressively
produce alarger fraction offemales, the dose
ofE2 required to sex reverse 50% ofthe ani-
mals decreases significantly(4). Furtherstud-
ies ofsteroid production provide a case for
the involvement ofsteroids in determining
the sex of the red-eared slider turtle.
Aromatase, the enzyme that metabolizes
testosterone to estradiol, is inhibited by
fadrozole and other inhibitors. When these
inhibitors are applied to eggs during the
TSP, incubation at a female-producing tem-
perature results in males (4). These findings
provide evidence that estrogens mediate the
temperature sex determination of females in
this species; inhibition of its synthesis results
in males, and application ofestrogens to pre-
sumptivemales results in females.
Although endogenous estrogens are
required for normal female turtle develop-
ment (which is not an adverse effect) and
thus normal sex ratios in turtle populations,
exogenous estrogens can be regarded as
developmental toxicants, irreversibly pro-
ducing inappropriate development of
females or, less frequently, intersexes at
temperatures that normally produce males
(3,5); both are adverse effects at the popula-
tion level.
Estrogen mimics and E2 have demon-
strated sex-reversal effects similar to those
shown by endogenous estrogens. When
hydroxylated PCBs are applied to eggs incu-
bated at all-male or male-biased tempera-
tures, females result (5). Other species pro-
vide evidence of altered development as a
result ofexposure to estrogen mimics. Male
fish swimming in effluent-polluted waters in
Great Britain exhibited feminization (8),
and a female-biased sex ratio is associated
with exposure ofgulls to environmental lev-
els ofDDT, a synthetic estrogenic chemical
(9). This association has been confirmed in
studies in which DDT applied to male gull
eggs resulted in feminized male embryos
exhibiting ovarian tissues and oviducts (9.
Risk assessments for virtually all chemi-
cals, except genotoxic chemicals, assume a
threshold dose belowwhich no adverse effects
occur (JO). This assumption underlies the use
of the no observed adverse effect level
(NOAEL), which is the dose that provides no
statistically significant increase in adverse
effects. To account for imprecision and
species extrapolation, this dose is divided by
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an uncertainty factor (often 100) to provide
the acceptable exposurevalues. The acceptable
exposure, consideredsafe, is rarelytested; thus,
safety depends on thevalidity ofthe threshold
assumption. This assumption (threshold
hypothesis) may not apply to chemicals that
share acommon mechanism with endogenous
chemicals important to normaldevelopment if
the threshold for the exogenous chemical
already is exceeded by the endogenous chemi-
cal (11-13). Administration of the same
chemical should lead to a curve showing no
threshold dose, no matter how low the back-
ground incidence caused by the endogenous
chemical (11). The criteria to refute the
threshold hypothesis are 1) evidence of
endogenous estrogen, 2) estrogen mediation
ofan irreversible effect (both satisfied by the
data for the red-eared slider turtle), and 3)
regression of the dose-response curve to the
origin or to a positive value on the y-
(response) axis (11-13). Using the red-eared
slider turtle, we tested the threshold hypothe-
sis for E2 and developed a biologically based
dose-response (BBDR) model.
Materials and Methods
Experimental. Freshly laid eggs obtained
commercially (Robert Kliebert, Hammond,
LA) were held at room temperature until
we established viability by candling. Eggs
were then placed in incubators in boxes (30
eggs each) containing vermiculite:water
(1:1 by volume) and incubated at 28.60C.
This temperature was chosen to provide a
large enough number of females to be
detectable, but small enough to give a
male-biased population. Temperature was
monitored daily using a HOBO tempera-
ture logger (Onset Computer Corporation,
Pocasset, MA) and frequent inspection of
calibrated thermometers on different
shelves (14). At Stage 17, the beginning of
the temperature-sensitive window (7), each
egg received one ofseven doses (Table 1) of
E2 dissolved in 5 ,ul 95% ethanol. This was
pipetted directly onto the eggshell. Each
treatment group initially contained 300
eggs divided equally into 10 boxes, with a
final sample size at hatch ranging from 253
Table 1. Comparison of estradiol dose-dependent
sex reversal in 1996 and 1997
Percentfemale ± SE
Dose (nglegg) 1996 1997
0 23.5±2.0 7.0±0.9
0.4 37.9 ± 3.5 25.5 ± 2.3
1.6 44.4 ±4.0 53.2±3.1
4.0 46.2± 3.1 76.8 ±6.2
7.0 65.0± 2.1 ND
17 82.2±2.5 ND
40 82.9 ± 2.3 ND
175 95.5 ± 1.6 ND
to 267 eggs/group. A control group (final
number = 240) was treated with 5 pl
ethanol. After treatment, all eggs were
returned to the incubator until they
hatched. During the entire period of incu-
bation, eggs were rotated daily from shelfto
shelf to avoid any 'shelfeffect" of tempera-
ture. Within 2 weeks of hatching, turtles
were anesthetized and sacrificed; gonadal
sex and development of oviducts were
examined, in a blinded manner, under a
dissection microscope by two researchers
and recorded. In all cases, macroscopic and
histological assessments agreed and were
consistent with the histological assessments
previously described (6). Results from two
boxes that were statistically significant out-
liers (out of a total of 80 boxes) were not
used. In the next breeding season, a repeat
study was conducted with the three lowest
doses (and a control) as described above,
with 55-62 animals (final number) in two
boxes to determine replicabiity in an inde-
pendent experiment.
The University ofTexas at Austin has an
approved Assurance from the Office of
Protection from Research Risks of the
National Institutes ofHealth (Assurance no.
A-1496). All protocols used in these studies
have been approved and reviewed by the
Institutional Animal Care and Use Committee
ofthe UniversityofTexas atAustin.
Michaelis-Menten ModeL A variant of
the Michaelis-Menten equation was devel-
oped. Maximum response is fixed at 100%
female, while the dose term consists of an
endogenous dose (do) plus the administered
dose (d); the dose providing a 50%
response is the EDs0 (or median effective
dose). The Michaelis-Menten model is as
follows: % female = 100(d + do)/[ED50 +
(d+dj)]. This can be rewritten as a simple
linear model in dwhere (% female/% male)
= (do/ED50) + (d/ED50). The intercept is
do/ED50 and the slope is 1/ED50. A nonit-
erative weighted linear least-squares proce-
dure was used to fit the model. Theweights
were the reciprocals of the standard devia-
tions of% female/% male among boxes for
each dose group. The sample size (n = 9 or
10 for the first experiment and n = 2 for the
replicate) was the number ofboxes used for
a dose group. Because the standard devia-
tion tended to increase with dose, the most
weight was assigned to the control and low
doses, the regions ofmost interest.
Results
Retrospective analysis ofpublished data on
sex reversal by varying doses ofE2 at three
different incubation temperatures (7,14)
revealed dose-response curves that fit a
Michaelis-Menten equation (Fig. 1). While
no threshold dose was observed, these results
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Figure 1. Retrospective analysis of the effect of
exogenous estradiol applied to eggs of the red-
eared sliderturtle incubated atdifferenttempera-
tures(7,12). At26.0°C(A),the i2and median effec-
tive dose values were 0.85 and 445 ng/egg,
respectively; at 28.2°C (B), these were 0.995 and
38 ng/egg; and at 28.6C (C), they were 0.998 and
31 ng/egg. Neither a line drawn by eye through
the points nor a Michaelis-Menten fit showed a
threshold dose.
were obtained from a relativelysmall number
ofanimals. Based on this outcome, we then
designed a large (2,400-egg) prospective
dose-response study to test further the
threshold hypothesis and the fit of the
Michaelis-Menten equation. The results are
shown inFigure 2. The curveregressed to the
y-axis at the control value (23.5%) for per-
cent female and to the negative x-axis at the
endogenous dose (di,) which was 1.7 ± 0.9
ng/egg (approximate 95% confidence limits).
The lower 95% confidence limit around do
was <0, indicating that regression to the ori-
gin or to the positive x-axis was unlikely
(p<0.003). The value for do is expressed in
the same units as applied dose and may or
may not reflect the actual concentration ofE2
in the egg. This is because in the egg, estradi-
ol biosynthesis occurs over time, whereas we
applied asingledose to theeggshell.
Using the modified Michaelis-Menten
equation, an ED50 of5.0 ng/eggwith 95%
confidence limits of ± 2.0 ng/egg (endoge-
nous dose = 1.7 ± 0.9 ng/egg; exogenous
dose = 3.3 1.8 ng/egg) and an r2 of0.90
were obtained for the fit ofthe equation to
the data points. The lowest dose adminis-
tered, 400 pg/egg (40 ng/kg egg weight),
significantly increased the female fraction
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Figure 2. A large prospective test ofthe no thresh-
old model using 2,400 red-eared slider turtle eggs
incubated at 28.6°C and treated with 170-estradiol
(0, 0.4, 1.6, 4.0, 7.0, 17, 40, and 175 ng/egg). The
Michaelis-Menten fit was as follows: % female =
100(d+1.7)/5 + (d+1.7). The solid line, calculated
from the equation, fits with an r2= 0.90. Dashed
lines indicate 95% confidence intervals. The line
strikes the dose axis at -1.7 ng/egg, providing the
predicted endogenous dose (do) in units of applied
dose (ng/egg). The median effective dose (ED50) of
5.0 ng is the sum of the endogenous and applied
doses(ED50 = 3.3 + 1.7 = 5.0 ng).
by 14.4%. A curve drawn by eye is virtually
identical to that found with the
Michaelis-Menten equation.
The replication of the three lowest
doses and the control is shown in Table 1.
In 1997 the control showed a lower frac-
tion of female turtles and a steeper
dose-response slope as compared to 1996,
with an ED50 of 1.3 ± 0.6 ng/egg and an
endogenous dose of 0.08 ± 0.28 ng/egg
(p<O.15). Thus, there is a 15% chance that
there is not an endogenous dose in the
repeat experiment. The smaller number of
eggs and boxes per group and the smaller
number of doses may account for the
inability to conclude at p<0.05 that an
endogenous dose exists. Another potential
explanation for these differences is that the
eggs were collected in the late summer in
1996 and in the late spring in 1997.
Combining the p-values from the two
experiments, the endogenous dose ofestra-
diol was significantly different from zero
(p< 0.01).
Discussion
In this unusually large study, we tested the
hypothesis that, even if a threshold exists,
no threshold dose is expected because
endogenous estrogens are at a sufficiently
high concentration to exceed the threshold
for sex reversal of red-eared slider turtles.
This is avariant ofthe hypothesis that ifan
adverse effect occurs due to an endogenous
chemical, no threshold dose is expected
(11). In turtles, endogenous estrogens pro-
gram normal sex reversal to provide an evo-
lutionary-derived appropriate sex ratio.
While the no-threshold hypothesis has
been in the toxicology literature for decades
(11-13), this is the first robust prospective
study in an experimental system that meets
the criteria for evaluation of a threshold.
Over 70,000 man-made chemicals that
have an aggregate value of billions of dol-
lars are found in food, water, air, or soil
(15). Given the central role of the thresh-
old assumption in evaluation ofhealth safe-
ty, the exposure ofall organisms to synthet-
ic chemicals, the importance of these
chemicals in modern society, and their
huge production volume and economic
value, it is surprising that the threshold
assumption has been so widely accepted
and so rarely tested. It is important that the
assumption ofa threshold is not a theory or
fact, but simply a pragmatic step in risk
assessments. The threshold assumption is
made in the absence of data contradicting
it, but has not been subjected to robust
direct experimental testing for any develop-
mental toxicant.
The threshold assumption is based on an
infinite regress. If a dose-response curve
appears to show no threshold, it can be
argued that the threshold could bedefined ifa
sufficient, perhaps up to an infinite, number
ofanimals were put on study. Contrariwise, if
the curve appears to show a threshold, it can
again be argued that there were insufficient
numbers ofanimals on the study to demon-
strate that a threshold exists. The solution to
this dilemma is to test the hypothesis as
described above and determine which model
(threshold or no threshold) is supported by
the simplest explanation (Occam's Razor)
(16). This hypothesis is not an infinite
regress, as we are interpolating between an
endogenous dose and the lowest applied dose
using a model of biological relevance that
utilizes all the data. The threshold/NOAEL
approach only uses one dose, the NOAEL.
Furthermore, simply connecting the data
points by eye with a smooth curve generates
an almost perfect replica of the Michaelis-
Menten curve. For the first experiment, the
interpolation traverses a very small dose dif-
ference; the control endogenous E2dose is
1.7 ng/egg, whereas the lowest dose of 0.4
ng/egg provides a total dose of 2.1 ng/egg
(the sum ofthe endogenous and exogenous
dose). The increase in E2 above the control
value is 23%. This should be contrasted with
the situation in cancer and radiation risk
analysis, where a no-threshold model is fre-
quently used. The difference between the
lowest dose tested and the background expo-
sure is about 100,000-fold (the lowest dose
will generally give a response rate of about
10%, and the curve is extrapolated to a risk
of one in a million), and different statistical
models lead to differences of 100-fold or
higher for an estimated acceptable exposure
(17). These differences arise because the
models assume different curve shapes. For
the turtle data, it would not be cogent to
draw a significandy different curve than that
presented, given the data points and the
knowledge that endogenous estrogens are
responsible for producing the female pheno-
type. Because the extent of interpolation in
our model is so small (23%) as compared to
that in cancer and radiation risk analyses and
because the curve shape is model indepen-
dent, the objections to the large uncertainties
found in the former extrapolations do not
applyto ourmodel.
The single-dose lowest observed adverse
effect level (LOAEL) for estradiol in the tur-
tIe (40 ng/kg) is slightly lower than the total
dose LOAEL in the developing fetal mouse
prostate in which diethylstilbestrol (DES)
doses were fed over 7 days (20 ng/kg x 7 =
140 ng/kg) (2). Additionally, the relationship
between the increase in dose and response is
similar to that found in the turtle. A 50%
increase in dose above endogenous levels
leads to a 30% increase in mouse prostate
weight, whereas in the turtle, a 23% increase
provides a 14.4% increase in response. These
are very low doses as compared to most of
those used in toxicology experiments and are
a consequence ofthe exogenous dose supple-
menting endogenous doses that are already
active in inducing responses. This empha-
sizes the need for lowenvironmental concen-
trations ofendocrine disruptors to be studied
with the mostdose-sensitive end points.
We have used a biologically based equa-
tion to generate a BBDR model that can be
used for dose-response and subsequent risk
assessments. This should be distinguished
from equations that carry no underlying bio-
logical significance, but only fit the line
based on a mathematical/statistical approach,
such as a polynomial equation with the asso-
ciated statistical parameters. The Michaelis-
Menten equation as normally used has no
threshold term (18), nor are thresholds
observed in analysis of receptor binding.
While low concentration curvature can be
found in Michaelis-Menten equations with
Hill coefficients >1, such curvature does not
represent a threshold, but a lower than
expected response compared to the unmodi-
fied equation. More complex BBDR models
are under development (10,19,20). These
use Michaelis-Menten kinetics to model the
pharmacokinetic and biological response
data. A theoretical receptor-mediated model
(19) and modeling of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (20) data sets strong-
ly suggest that thresholds are not generated
by hormone-receptor interaction and are
unlikely when an endogenous chemical is
active. Our model predicts the endogenous
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dose when it exists. The dose fit oforganis-
mal data to the Michaelis-Menten equation
suggests that sex reversal is driven by a single
rate-limiting, reversible binding event analo-
gous to enzyme kinetic studies showing that
substrate binding is the rate-limiting step,
not the conversion ofsubstrate to product.
For receptor-mediated responses, the rate-
limiting step is assumed to be liganded estro-
gen receptor binding to DNA response ele-
ments (19,20). While numerous events such
as absorption, distribution, metabolism, and
elimination occur between the application of
the dose to the eggshell and the arrival of
hormone to the receptor target, theywill not
influence the shape of the dose-response
curve ifthey are not rate-limiting, but they
can have an impact on potency.
The BBDR model demonstrates that
no exogenous E2 is without risk (as
opposed to the threshold assumption) and
requires that an acceptable risk level be
defined and the corresponding exposure
calculated directly, in contrast with the tra-
ditionally derived exposure levels. Just as a
threshold is not predicted to lie between
two exogenous doses on the ascending por-
tion ofthe dose-response curve, it is illogi-
cal to assume that a threshold exists
between the control endogenous dose and
the lowest exogenous dose in our model.
The fit of the Michaelis-Menten model
was slightly better with a Hill coefficient of
1 compared to 2, but because most ofthe
curvature in the latter case is in the low-
dose region of the dose-response curve
(i.e., in the endogenous dose region), good
resolution was not feasible. However, in
the replication, the control value was lower
and the curve showed no low-dose curva-
ture. These considerations, taken with the
fit of the large data set to the
Michaelis-Menten equation, the three
analyses in Figure 1, and the replication
study, argue for our conclusions that no
threshold dose exists. In the absence of a
threshold dose, there will be risk at any
dose, no matter howlow (11).
Risk assessment assumptions are often
made in the absence ofdata; this is the first
report ofa robust prospective experimental
test ofthe threshold hypothesis for a devel-
opmental toxicant. These results are consis-
tent with the finding that no dear thresh-
old exists either for exogenous E2-induced
enlargement of the fetal mouse prostate,
the size ofwhich is controlled, in part, by
endogenous estrogens (2) or for adverse
effects ofestrogens on thyroid hormone in
the developing rat (21). Likewise, a large
conventional teratology experiment with
2,4,5-trichlorophenoxyacetic acid was con-
ducted using five mouse strains with 4-10
replicates each and 548-1,154 pregnant
dams per strain experiment; no threshold
was discernable (24. The criteria we have
established were used to examine published
data from endocrine-active chemicals;
responses ranging from the expression of
single genes through physiological respons-
es to adverse effects were found to fit a
Michaelis-Menten equation with high cor-
relation coefficients for 15 chemicals (23).
These criteria should be used to prospec-
tively examine other endocrine disruptors
and outcomes across diverse species to
determine the extent to which no-threshold
models are applicable. There are clear cir-
cumstances in which this would be inap-
propriate: if the endogenous hormone is
absent or induces no response, a threshold
would be expected. However, ifanylevel of
response occurs, even if experimentally
undetected due to insufficient resolving
power, no threshold is expected (11). The
procedure described here allows risk assess-
ments to be conducted with knowledge of
actual or estimated risk in the observed or
interpolated dose range, respectively. Our
approach allows a more informed decision
by risk assessors, in contrast with the
NOAEL/uncertainty procedure in which
no riskis estimated.
The issue ofwhether sex reversal is an
adverse effect is important. Thedefinition of
a response as adverse is frequently controver-
sial in risk assessments. We need to distin-
guish traditional adverse effects, which may
be based on dearhistopathology, from non-
pathological events that are adverse. In the
case of turtle sex reversal by xenoestrogens,
the females should be fertile, assuming no
other adverse effects ofthe xenoestrogen on
reproduction. However, sex reversal leading
to reproductively capable females can have
adverse demographic consequences. Clearly,
athigh rates ofsexreversal, the reproduction
ofpopulations will be compromised. This is
a dear adverse effect. But what about lower
rates of sex reversal? These, too, could be
adverse effects, depending on whether other
events such as habitat loss, predation, global
warming (which is particularly applicable in
TSD animals), orotherstressors occur at the
same time. A principle of ecology is that
four characteristics determine population
density: age structure, survival rate, fecundi-
ty, and sex ratio (24,25). Sex reversal by
xenoestrogens clearly alters the sex ratio and
can thus impact population density and sur-
vival. Importantly, exposure to a mixture of
estrogenic endocrine disruptors could lead
to a high rate ofsex reversal, although each
chemical by itself may induce a low sex
reversal rate. For xenoestrogens, the large
majorityofchemicals examined act as full or
partial agonists, with the exception ofantie-
strogenicdrugs (26).Additionally, chemicals
can act as agonists in one tissue but antago-
nists in another (22). Given this, it is unlike-
ly that antagonists in a mixture would con-
tribute significantly to decreased adverse
effects, although this will depend entirely on
the components of the mixture and their
concentration. The EPA has developed a
toxic equivalency (TEQ) factor approach for
mixtures such as dioxins (28). The TEQ is
the sum ofthe concentrations ofeach chem-
ical times their potency, where TCDD has a
potency of 1. Risk assessments are then
based on the mixture's TEQ. This avoids
the possibility ofsetting an acceptable expo-
sure level for each chemical individually,
with the potential consequence that expo-
sure to a mixture would result in adverse
effects. The same approach would be appro-
priate for risk assessments for xenoestrogen-
inducedsex reversal.
It can be argued that the increase in the
female fraction at low doses is within the
normal fluctuation in sex ratio in this species
and is therefore not adverse. However, no
matter the extent of fluctuation, there will
always be an added effect ofestrogen expo-
sure such that the female fraction is
increased. Consequently, thepopulation dis-
tribution is shifted to a higher proportion of
females, which can interact with other pop-
ulation stressors to contribute to population
declines. Thus, the real issues are the
increased risk due to exposure to xenoestro-
gens, either from an individual chemical or a
mixture, and how little exposure is too
much for population stability under a vari-
etyofenvironmental conditions.
All crocodilians, many turtles, and
some lizards have TSD (4). Thus, the
potential for sex reversal by environmental
estrogens has implications for many
wildlife species. Additionally, the threshold
hypothesis should be tested in other non-
TSD animal models for chemicals that
mimic the actions of estrogens and other
endogenous signaling chemicals. Naturally
occurring and synthetic chemicals found in
the environment, such as coumestrol,
DDT, and PCBs, produce classical estro-
genlike effects in animals (5,9,29-31).
Many estrogenic endocrine disruptors
operate through the same mechanism as E2
(24); importantly, at lowdoses, such chem-
icals can therefore increase rates ofnormal,
active endocrine processes. The red-eared
slider model, which provides a sensitive
bioassay for these chemicals, should be
used to explore the threshold issue for a
varietyofestrogenic endocrine disruptors.
Based on current risk assessment proce-
dures, global environmental chemical con-
centrations are generally thought to be too
low to exert adverse affects when compared
to their traditionally calculated acceptable
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exposure levels. We demonstrate dose-
dependent risk at any dose ofexogenous E2,
no matter howlow, thereby providing a bio-
logically justified explanation for low-dose
effects of endocrine disruptors. Numerous
endogenous chemicals serve critical determi-
native roles at specific times in organismal
growth and differentiation; these are the fre-
quently encountered circumstances in which
no threshold dose is expected. Therefore, we
expect our condusions are not idiosyncratic,
but rather are widely applicable. Our find-
ings and their implications reinforce our
concern for the health of humans and
wildlife exposed to these lowdoses.
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